Somatogen (SMTG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ford Investor who wrote (345)	12/18/1997 11:46:00 PM
From: Bharat H. Barai	Read Replies (2) of 442

Dear Steve, Somatogen is an orphan stock. The performance is very disheartening. The stokcs are priced on who wants to buy or sell. Clearly it is very disappointing for people like me and others who have followed the science, not market. This sell off is most probably related to tax selling. Until the company comes up with some positive news, I doubt the stock will perk up. The stocks move on news or earnings. Neither is happening here. Stock fundamentals are unchanged. Bharat H. Barai MD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next